• Lynx Capital 德石资本

    Healthcare Focus, Global Resource, China Angle

  • Who We Are

    Lynx Capital is a healthcare and life science -focused fund, investing in innovative companies in western countries in both therapeutics and medical technology areas, with a potential to collaborate with Chinese companies to explore the China market. With the extensive expertise and experience in both China and the States, and deep understanding of healthcare and business, Lynx Capital believes that it is well positioned to help with such collaboration.

  • Portfolio News


    Edinburgh, Mar 8, 2023 -- Calcivis, dental imaging technology company, is setting its sights on US growth having secured pre-market approval (PMA) from the US Food and Drug Administration (FDA). As the first Scottish medical device to secure the coveted accreditation, the Calcivis Imaging System aims to revolutionise the dental sector by enabling the move to a more preventive treatment model.

  • The Blog

    Thoughts, musings, and ruminations.

    There are no published blog posts yet.